Certara Products Archives

Press Release

Certara Reports Third Quarter 2025 Financial Results

RADNOR, PA— November 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraNovember 6, 2025

Press Release

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

CertaraOctober 30, 2025

Blog

At Certara, we’re proud to support WBUR, Boston’s NPR.

Certara supports public radio because NPR is aligned with our values and helps us spread…

CertaraOctober 29, 2025

Blog

Best Practices for AI Prompt Engineering in Life Sciences in 2025

AI prompt engineering is an essential skill for using LLMs. Read our blog for best…

CertaraOctober 23, 2025

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraOctober 15, 2025

On-Demand Webinar

Avoiding the MedChem Mutiny

CertaraSeptember 22, 2025

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Announcement

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…

CertaraSeptember 17, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

CertaraSeptember 5, 2025

On-Demand Webinar

Streamline Table Creation with AI-Specialized for Regulatory Writers

Learn how AI-powered CoAuthor™ transforms table creation for regulatory and medical writers. Watch our free…

CertaraAugust 27, 2025

Certara Products